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Abstract
We analysed the relationship between drug use and wellbeing using data from the Crime 
Survey for England and Wales. We focused on cannabis use, the most commonly used 
drug, but also controlled for use of other drugs, alcohol consumption and a range of poten-
tial confounds. Measuring life satisfaction on a 0–10 scale, linear models found that peo-
ple who had never used cannabis had significantly higher scores than current users (0.54). 
Never having used other types of drugs was also associated with 0.37 extra life satisfaction 
points. Moderate alcohol use (1–2 days per week) was associated with higher life satisfac-
tion than abstainers or more regular drinkers. Following the “life satisfaction approach”, 
we estimated the extra income that would be needed to compensate for the wellbeing loss 
associated with cannabis use. Accounting for income endogeneity, our results suggested 
that being a current cannabis user may cost an individual over £5600 per year, in terms of 
lost wellbeing, while being a current user of other drugs may cost approximately £4000 per 
year. While acknowledging possible reverse causality, we estimated the annual population 
cost of drug use may be as high as £10.7bn in terms of lost wellbeing.
Keywords Drug use · Cannabis · Life satisfaction · Wellbeing · Compensation value · 
CSEW
1 Introduction
Although illicit drug use appears to be slowly declining in England and Wales, the best 
available evidence still suggests that as many as 1 in 12 (8.4%) of adults aged 16–59 years, 
or 2.7 million people, took illegal drugs in 2015/2016 (Office for National Statistics (ONS) 
2016a). Drug use is the subject of much debate, with a significant body of research focused 
on the potential negative effects drug use might have on user’s psychological health and 
wellbeing (e.g. Brook et  al. 2002; Levy 2008; Allen and Holder 2014). Some have sug-
gested that access to certain drugs may positively affect wellbeing: Anderson et al. (2014) 
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found for example lower suicide rates in the US states where cannabis has been legalised 
for therapeutic purposes. It is in this context that we examined the association between 
wellbeing, in terms of an individual’s overall satisfaction with life, and drug use, using 
special license data drawn from the Crime Survey for England and Wales (CSEW). Given 
that the CSEW also provides information on household income, we also attempted to value 
the economic cost of taking drugs on wellbeing using the “life satisfaction approach”, 
an approach increasingly used in the literature to assign a monetary value to non-market 
goods (e.g. Her Majesty’s Treasury (HMT) 2011; Oswald and Powdthavee 2008; Tsu-
rumi and Managi 2016). Of course, establishing causality on this issue is difficult (Moore 
et al. 2007) as drugs may not just influence life satisfaction—either directly through their 
consumption or via the detrimental health and social consequences of consuming drugs 
(Allen and Holder 2014)—but drug taking may also be a coping strategy to deal with low 
wellbeing levels (Miller and Plant 2002). Although our cross-sectional data cannot directly 
answer issues of causality we were still able to explore whether an association between 
drug use and wellbeing exists controlling for a range of potential confounders such as 
health, employment and marital status, and attempt to quantify any relationship in mon-
etary terms. This allowed us to compute the overall cost of taking drugs at the national 
level, and to compare it in magnitude to the cost of other well-recognised social problems, 
such as smoking and air pollution.
The current research focused on the use of cannabis and other drugs (combined). Can-
nabis was explored separately as it was by far the most widely used drug in the CSEW 
dataset. The remaining drugs were combined, despite potentially having different relation-
ships with wellbeing, because our sample included too few individuals in each specific 
drug category, rendering analysis and interpretation at this level of specificity unreliable. 
This is consistent with earlier findings. For instance, previous work has reported the next 
most popular drugs after cannabis (6.6% of the adult population) are powder cocaine and 
ecstasy, with annual levels of use of just 2.4% and 1.6% respectively (ONS 2014a). We 
also distinguished between three groups of individuals1: those who report never having 
used the drug (never users); those who have used the drug in their life but not in the last 
12 months (past users); and those who have used the drug in the last 12 months (current 
users). We were unable to explore use frequency in more depth as this information is not 
provided in the dataset. Nevertheless, inferences about use frequency can be made based 
on the 2014a ONS data, which suggests that 43% of current cannabis users use it more 
than once a month, while users of other types of drug do so less frequently (e.g. only 13% 
of powder cocaine users, 12% of amphetamine users and 4% of ecstasy user use the drug 
more than once a month). Finally, given the much wider use of alcohol, we also compared 
the relationship with alcohol use and wellbeing with drug use and wellbeing to contextual-
ise our findings.
The paper is organised as follows. Section 2 reviews the literature on the association 
between drug use and wellbeing. Section 3 presents the data and descriptive statistics. Sec-
tion 4 presents the empirical strategy, including the regression model and the computation 
of the cost of drugs using the life satisfaction approach. Results are presented in Sect. 5 and 
discussed in Sect. 6, where the overall wellbeing benefit that could potentially be enjoyed 
by giving up drugs at the national level is also computed. Section 7 summarises the find-
ings and the last Section concludes.
1 This distinction is made also by MacDonald and Pudney (2000).
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2  Literature Review
2.1  Drugs and Wellbeing
Substance misuse is an important social issue, associated with a range of mental health 
problems (Moore et al. 2007) and antisocial behaviour and crime (Bennet and Holloway 
2005; Bennet et al. 2008), in part to fund drug use itself (Bennet et al. 2008; Cross et al. 
2001; Kopak et al. 2014).
2.1.1  Impact of Drugs on Wellbeing
A considerable body of research has suggested that use of drugs may lead to lower well-
being and particularly to the development of depressive symptoms in later life following 
early consumption (e.g. Brook et  al. 2002), but it is unclear whether this relationship is 
due to the drug itself or due to the circumstances surrounding its use. For instance Sem-
ple et al. (2005) argued that depressive symptoms associated with methamphetamine use 
are not merely due to negative life circumstances associated with drug use such as poorer 
employment, health and family, but can be directly attributed to the use of the drug itself. 
By contrast, using a sample of undergraduate students, Allen and Holder (2014), argued 
that it is the circumstances around the use of marijuana (e.g. poor attendance and academic 
performance), rather than the chemical substance itself, which is associated with poorer 
wellbeing. Although clearly an important issue for future study, this distinction is less rele-
vant to the current research which focused mainly on an estimate of the costs of this loss on 
wellbeing rather than the complex causal pathways through which it might have operated. 
Moreover, some studies have found a positive relationship between drug use and wellbe-
ing. It has been shown that marijuana legalization is associated with decreasing suicide 
rates, which may be partially the result of a decrease in alcohol consumption (Anderson 
et al. 2014).
2.1.2  Other Factors Playing a Role in the Drug–Wellbeing Relationship
Theoretical (Arnett 2005) and empirical contributions (Miller and Plant 2002) have pointed 
out the existence of other factors associated with substance use, suggesting for example 
that using drugs may be a strategy to cope with low levels of wellbeing. In a study on a 
sample of adolescent cannabis users, Miller and Plant distinguished between three different 
types of users. First, people using the drug for recreational purposes; second, those who 
used drugs within a wider context of anti-social delinquent behaviours; third, individuals 
that felt unsatisfied with how their life was going, using the drug for “self-medication”. 
Levy (2008) also theorised that individuals from low socioeconomic groups consuming 
drugs for self-medication may end up trapped in a “vicious circle” due to the negative 
effect of drugs on employment and social outcomes.
These results lead to some reflections. The first is that it is not surprising that drug use 
is more widespread among younger people, especially in the case of recreational drugs 
taken when together with friends. ONS (2016a) data, for example, shows that in England 
and Wales 18% of people aged 16–24 years have used drugs at least once in the last year, 
against 8.4% in the broader category of 16–59 years. The early twenties represents an age 
in which the control from parents starts weakening—especially in the case of students liv-
ing away from home (see Bennet and Holloway 2015 for a comparison between students 
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and non-students), that have not yet experienced that “turning point” in life (i.e. starting 
employment or starting a family) associated with a greater degree of social control that dis-
courages delinquent behaviour in general (Corman et al. 2011; Walker et al. 2013). Levitt 
(1998) also showed that coming of age is associated with a sharp decrease in crime rates in 
general, this being higher the severer the punishments for adults are compared to those for 
youths. Along these lines, Arnett (2005) theorized that so-called “emerging adults” using 
drugs consider this a “behaviour that is acceptable at their current age but one that they 
will give up in the course of growing into adulthood” (p. 247).
Second, personality plays an important role in drug use. Arnett (2005) hypothesised 
that optimistic individuals are more likely to use drugs, as they tend to underestimate 
the harmful effect drugs can have on their life. Along these lines, Peretti-Watel (2006) 
found that cannabis users have higher scores of risk denial compared to non-users. In the 
study by Allen and Holder (2014) marijuana users tended to score higher in “Openness 
to experience” and lower in “Agreeableness” and “Conscientiousness”. This is consist-
ent with the results by Tartaglia et al. (2017b). Allen and Holder (2014) also found that 
the negative social consequences of the drug are more severely felt by individuals high in 
“Neuroticism”.
The third reflection is about the issue of reverse causality in the drug-wellbeing link. 
Among the papers reviewed by Moore et al. (2007), one of the most appropriate and com-
monly used methods to deal with the problem appears to be using panel data and con-
trolling for the presence of mental health problems at some point earlier in time. In our 
research, given the cross-sectional nature of the dataset used, we were not able to fully 
address this issue. In order to reduce the bias associated with it, we controlled for a number 
of personal characteristics, such as health status, employment condition and marital status, 
which could at least in part explain the endogeneity issue. We are also aware that there may 
be a reciprocal association between wellbeing and income with happier people tending to 
earn more, even some years later (De Neve and Oswald 2012), and higher income (even 
through lottery wins) associated with greater well-being (possibly after a lag period, Gard-
ner and Oswald 2007). We attempted to account for this using an instrumental variable 
approach proposed by Fujiwara et al. (2014, see Section 4.3).
2.2  Alcohol Consumption and Wellbeing
In this paper we also controlled for the link between wellbeing and alcohol consumption, a 
theme which has been already analysed by part of the literature. Gil-Lacruz and Gil-Lacruz 
(2010) found evidence of a significant effect of drinking on the prescription of tranquilizers 
among Spanish adolescents, holding also when taking into account reverse causality issues. 
Baumberg Geiger and MacKerron (2016) analysed data from the British Cohort Study and 
found that heavy drinking is a significant predictor of lower wellbeing. A similar result is 
also reported by Dietze et al. (2013) in an analysis on a sample of injection drug users that 
found a significant negative effect of drinking on wellbeing, even controlling for type and 
intensity of drug use. On the other hand, other studies have suggested that drinking may be 
a way to cope with stress and anxiety (Lanier et al. 2001; Tartaglia et al. 2017a).
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2.3  The Welfare Cost of Drug Use
The current research extends most previous work by going beyond exploring the asso-
ciation between drug use and wellbeing and attempting to also evaluate the cost of 
drug use using the “life satisfaction approach”. This relatively novel approach (pre-
sented in more detail in Sect. 4) draws upon the analysis of the relationship between 
life satisfaction and income to compute the equivalent value of a range of non-mar-
ket goods (HMT 2011), such as social relationships (Powdthavee 2008; Orlowski and 
Wicker 2015) and marriage (Qary 2014). In the same way, it is used to calculate the 
equivalent amount of money that would be needed to compensate for the existence of 
problems, such as housing problems (Fujiwara 2013) and negative life events, such 
as experiencing unemployment (Powdthavee 2008) or the death of a family member 
(Oswald and Powdthavee 2008).
To the best of our knowledge, only Powdthavee and van den Berg (2011) have used 
the life satisfaction approach in the context of drug use, focusing in particular on alco-
hol and drug problems, along with a number of other health issues. In their paper, they 
used BHPS panel data and distinguished between a level and a shock effect of income 
and health problems, reflecting respectively how the average value of these variables, 
as well as their annual shift from the average, affects life satisfaction. Their results sug-
gested that, overall, “relief from alcohol and drug related problems” is worth approxi-
mately £9 million a year/per person. Clearly this amount seems very high and thus the 
approach was further elaborated by Fujiwara (2013). Specifically, Fujiwara used an 
instrumental variable approach to deal with the endogeneity problem in the income-
wellbeing relationship. Using an unbiased coefficient for income and drawing upon the 
health problems coefficients estimated by Powdthavee and van den Berg (2011), Fuji-
wara concluded that overcoming alcohol and drug problems is worth £24,000 a year/
per person, a much lower, probably more realistic figure. The current research pre-
sents findings using both approaches for comparison (though of note unlike the BHPS 
there is no within-person variance over time in our cross-sectional data so we are not 
directly comparing like with like).
The life satisfaction approach measures the value of non-market goods and life 
events looking at how they impact subjective wellbeing, i.e. reflecting the point of 
view of the individual. A different perspective—looking mainly at the costs of drug 
use for the society—is instead the focus of another part of the literature (e.g. Lievens 
et al. 2017). Within this literature, the direct drugs-related health and crime expendi-
tures imposed to the society are taken into account together with the indirect produc-
tivity losses and intangible quality of life losses. This approach was taken by the Drug 
Treatment Outcomes Research Study (DTORS). This study measured the benefits of 
treating drug problems using follow-up interviews on a sample of approximately 1800 
individuals being treated in a structured setting in England (Davies et al. 2009; Don-
mall et al. 2009). DTORS took into account the benefits of the treatment in terms of 
health outcomes, as measured by Quality Adjusted Life Years (QALYs), and avoided 
costs for society from reduced criminal misconduct and lower access to public services 
to deal with health and social problems. Results suggested a total benefit per person of 
approximately £6500 a year, with a benefit-cost ratio of about 2.5:1. Given that this is 
a much broader impact assessment than that used by the life satisfaction approach it is 
interesting to see how much lower this figure is even compared to Fujiwara’s (2013) 
£24,000 a year/per person.
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2.4  Contribution to the Literature
In sum, the current paper contributes to the existing literature by using data drawn from 
the Crime Survey for England and Wales to explore how reported use of drugs is related to 
life satisfaction and, following Powdthavee and van den Berg (2011) and Fujiwara (2013), 
attempted to value the individual cost associated to taking drugs, in terms of wellbeing 
loss. The current research distinguished between cannabis and other drugs and between 
current users, past users and never users. As far as we aware, this is novel and sheds light 
on the wellbeing costs of different types of drugs. Our analysis has been partly limited by 
the cross-sectional nature of the available data. In fact, we are not able to draw causal con-
clusions on the drug use-wellbeing relationship. Nevertheless, we have tried to address the 
reverse causality issue by including a number of socio-demographic covariates which are 
likely to play a role in this relationship, in order to partly mitigate the problem. Moreover, 
in dealing with the relationship between income and wellbeing, we have drawn upon the 
findings of previous studies, in an attempt to provide unbiased measures of the monetary 
cost of drug consumption. The computed figures were then used to extend our findings to 
compute the overall cost of taking drugs at the national level. Finally, along with the cost 
of drugs, the value of drinking alcohol was measured, as a function of drinking frequency.
3  Data and Descriptive Statistics
The data used in this analysis was the 2013–2014 Crime Survey for England and Wales 
(CSEW), a survey representative of the population living in private households in England 
and Wales. For each household in the sample, one adult is randomly selected to be inter-
viewed (ONS 2015a). The CSEW mainly investigates whether the respondent has been a 
victim of criminal offences and his perceptions and attitudes towards crime. However, the 
questionnaire also includes self-completion modules collecting information about the con-
sumption of drugs and alcohol, the engagement in anti-social behaviours, together with 
questions on subjective wellbeing (ONS and TNS 2014). The drugs and drinking modules 
are administered only to individuals aged 16 to 59, while the questions on wellbeing are 
asked only to a further subsample of observations (approximately 5200 individuals provide 
a valid answer to the question on life satisfaction). Once observations with missing informa-
tion were excluded, our sample consisted of 4405 observations, made up of 2038 men and 
2367 women aged 16 to 59—the age group to which self-completion modules are directed.
The variables used in the analysis were the following.
Life satisfaction Life satisfaction is measured through the question “Overall, how satis-
fied are you with your life nowadays?” Responses are reported on a 0–10 scale, where 0 
indicates “Not at all” satisfied and 10 indicates “Completely” satisfied.
Drug use The data investigate the use of different types of drugs: amphetamines, meth-
amphetamines, cannabis, cocaine, crack, ecstasy, heroin, acids, magic mushrooms, metha-
done, tranquillizers, poppers, anabolic steroids, ketamine, mephedrone and other unknown 
drugs. For each type of drug, the respondent is asked whether s/he has ever taken the drug 
in his life and whether s/he has taken the drug in the last 12 months. For the purpose of this 
analysis, we looked at cannabis and we collapsed all other drug categories into a single 
variable capturing any other drug. We then distinguished between three categories of indi-
viduals: those who have never used the drug; those who have used the drug in their life but 
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not in the last 12 months (past users); those who have used the drug in the last 12 months 
(current users).
Alcohol use The CSEW collects a number of questions on alcohol consumption. In this 
analysis we looked at the consumption of alcoholic drinks in the last month, distinguishing 
between the following response-categories: never, less than a day a week, 1–2 days a week, 
3–4 days a week; 5 or more days a week.
Income The CSEW collects information about gross household income in several cat-
egories. For current purposes, we computed the equivalised household disposable income 
for each individual using data on household composition and using the median income 
value of the corresponding income category. To do this we used ONS income statistics 
(ONS 2015b),2 and focused in particular on the ratio between gross and disposable income 
by level of income in the UK. Finally we followed the OECD-modified scale to compute 
the equivalised household size3 and consequently the equivalised household disposable 
income for each observation.
Equivalised income was used both in absolute terms and in logarithmic form in our 
analyses. The two functional forms imply a different relationship between life satisfaction 
and income, with the logarithmic transformation suggesting that it is the relative change in 
income rather than the absolute change that affects wellbeing, which some authors claim is 
a better representation of the income-wellbeing relationship (Kahneman and Deaton 2010).
Additional controls Additional controls were gender, age measured in three categories 
(16–24  years; 25–44  years; 45–59  years); marital status (single; married or cohabiting; 
separated/divorced and widower); education (A-level; degree; any other educational level); 
employment status (employed; unemployed; student; any other inactive); health status, 
measured on a 5-point scale ranging from very good to very bad; and number of cohabiting 
children.
Summary statistics of the variables are presented in Table 1.
Table  1 shows that the observed equivalised disposable income was on average 
£17,817.4 Life satisfaction was 7.36 on average, consistent with ONS (2014b) official sta-
tistics of approximately 7.5 for England and Wales. As for drug use, approximately one-
third of the sample reported having used cannabis at least once in their life, with almost 6% 
being current users (consistent with ONS 2014a data) and 27% being past users. Consump-
tion of other drugs was much lower: 78% of the sample reported never having tried any 
other drug in their life, with approximately 4% being current users (again consistent with 
ONS 2014a data) and 18% being past users. In terms of alcohol consumption, non-drinkers 
made up 14% of the sample and around one-third reported drinking less than one day a 
2 The statistics for 2014/15 have been used for their higher level of detail respect to statistics for 2013/14.
3 The OECD-modified equivalence scale assigns a value of 1 to the head of the family, 0.5 to all other 
adults and 0.3 to children aged less than 14. In this analysis, due to the lack of relevant information in the 
data, we used the age of 16 to distinguish between adults and children.
4 The official statistic provided by ONS (2015b) on household disposable income for the financial year end-
ing in 2014 is £29,477. However, ONS uses a different equivalence scale assigning 0.67 to the first adult, 
0.33 to the second and subsequent adults, and 0.20 for children aged 13 years and under. Using this equiva-
lence scale, the comparable equivalised income of our sample is £26,187—approximately 10% less than 
the official figure. The difference between the official figure on household disposable income and the one 
observed on our sample is instead approximately 8% (respectively £31,786 and £29,265), suggesting that 
part of the difference in terms of equivalised income derives from a slightly larger (equivalent) household 
size of our particular sample. One of the reasons behind this is that the sample age is restricted to be less 
than 59—due to the survey design. Therefore, this excludes all households made up of single elderlies and 
increases the average household size.
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Table 1  Descriptive statistics. Source: Elaborations on CSEW 2013/14
M SD
Life satisfaction [0–10] 7.35 2.00
Equivalised disposable income 17,817 12,183
Number of children 0.66 0.99
%
Cannabis use
 Never 67.85
 Past user 26.58
 Current user 5.56
Other drugs
 Never 77.96
 Past user 18.30
 Current user 3.75
Alcohol consumption
 Never 13.62
 Less than a day a week 33.23
 1–2 days a week 30.94
 3–4 days a week 14.48
 5+ days a week 7.72
Gender
 Male 46.27
 Female 53.73
Marital status
 Single 41.16
 Married/cohabiting 43.47
 Separated/divorced 14.03
 Widowed 1.34
Age group
 16–24 11.94
 25–44 48.01
 45–59 40.05
Health status
 Very good 43.22
 Good 41.27
 Fair 11.24
 Bad 3.63
 Very bad 0.64
Education
 Degree 44.70
 A-level 20.16
 None/other qualification 35.14
Employment condition
 Employed 78.66
 Unemployed 4.54
 Student 2.86
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week. A further third reported drinking 1 or 2 days per week (the group with the high-
est wellbeing according to Lanier, Nicholson, and Duncan 2001), 14% reported drinking 
3–4 days per week and approximately 8% reported drinking more frequently.
4  Empirical Strategy
4.1  The Empirical Model
In terms of our empirical model, we ran a regression analysis of life satisfaction over drug 
use, alcohol consumption, income and the above-listed set of socio-demographic variables. 
In particular, we estimated the following model:
where LSi is the life satisfaction level of individual i, Di is a vector of drug related var-
iables, Ki is a vector of drinking related variables, Mi is equivalised disposable income, 
which enters in the equation in either absolute form (specification (1)) or logarithmic form 
(specification (2)). Xi is a vector of controls, including gender, age, marital status, employ-
ment condition, health, education and number of children, and 휖i is an error component. 
The vectors 휷 , 휸 , and 훿 inform us respectively of the association between wellbeing and 
drug use, drinking and income, while the vector 휽 describes its association with the soci-
odemographic control variables.
Taking current drug users as a reference category, we estimated the coefficients related 
to never and past users (respectively 훽never drug , and 훽past drug ), distinguishing between can-
nabis and other drugs.
4.2  The Welfare Cost of Taking Drugs
In the life satisfaction approach, the welfare cost of being a current drug user can be defined 
as the amount of money individuals would need to receive to compensate them for the det-
rimental effect taking the drug has on their wellbeing, relative to never and past users. This 
has been referred to as the “shadow price” (Powdthavee and van den Berg 2011) or “com-
pensation value” (Fujiwara 2013; Fujiwara et al. 2014). The compensation value of being a 
current versus never drug user is computed as follows:
(1)LSi = 훼 + D�i휷 + K
�
i
휸 + 훿Mi + X
�
i
휽 + 휖i
(2)Compensation Value specification (1) =
훽never drug
훿
(3)Compensation Value specification (2) = e
[
훽never drug
훿
+ln (M0)
]
−M0
Table 1  (continued)
%
 Other inactive 13.94
N 4405
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where M0 represents the initial income level—in this case we use the average equivalised 
income of the sample, while 훿 is the coefficient measuring the impact of income on wellbe-
ing. 훽never drug represents the extra satisfaction a person who has never used drugs enjoys 
compared to a current user. In a similar way, we can compute the compensation value of 
being a current user to that of a past user.
For both specifications, the cost of taking the drug is linked to the income coefficient 
in an inverse relationship. In the semi-log specification, the cost increases with increasing 
initial income level.5
4.3  The Endogeneity Problem
As noted above there may be a reciprocal relationship between income and life satisfac-
tion (De Neve and Oswald 2012), with not just income making people more satisfied, but 
also happier people being more confident and motivated on their job, this leading to an 
higher income level. Moreover, several unobserved factors are likely to affect both vari-
ables, resulting in additional sources of endogeneity (Powdthavee 2010). The estimated 
coefficient 훿 , measuring the impact of income on wellbeing, is therefore likely to be biased. 
To overcome this endogeneity problem, a number of instrumental variables have been used 
in the empirical literature. Fujiwara et al. (2014) and Apouey and Clark (2015) have, for 
example, used lottery wins as an instrumental variable for income, following the work 
previously done by Gardner and Oswald (2007). Alternative instrumental variables used 
were industry sector (Pischke 2011) and the information about the proportion of household 
members using a payslip to answer the question about income (Powdthavee 2010). The use 
of instrumental variables usually leads to an higher income coefficient compared to OLS. 
Higher income is in fact usually associated with higher overtime working hours which 
increase stress and negatively affect work-life balance (Golden and Wies-Tuers 2006), as 
well as with increasing comparison incomes (Ferrer-i-Carbonell 2005).
No suitable instrumental variable was available in the CSEW. Therefore we followed 
Fujiwara et al. (2014) in retrieving the unbiased estimated coefficient for income 훿 from 
another model to compute the “unbiased” cost of using drugs. This should not be a prob-
lem insofar as this is estimated on a representative sample of the same population (this and 
other issues are further discussed in the Appendix).
We retrieved the “causal effect” of income from the papers by Fujiwara et al. (2014)—
using lottery wins as an instrument—and Powdthavee (2010)—using the information about 
the use of a payslip during the interview. Using the unbiased income coefficient 훿∗—drawn 
5 In the linear specification, the Compensating Value for being a current vs. never drug user is derived by 
equating the following equations:
 
 As for the semi-log specification, the equations are:
 
 In the latter case, the CV is likely to be higher, as the logarithmic form tends to reduce the effect of any 
additional income.
LSCURRENT DRUG = 훿(M0 + CV)
LSNEVER DRUG = 훽never drug + 훿M0
LSCURRENT DRUG = 훿ln
(
M
0
+ CV
)
LSNEVER DRUG = 훽never drug + 훿ln
(
M
0
)
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from either Fujiwara, Kudrna, and Dolan (2014) or from Powdthavee (2010)—to compute 
the “unbiased” compensation value, Eq. (3) can be rewritten in the following way:
5  Results
Table 2 reports the results of the estimated model, with income modelled using the linear 
specification presented in column 1, and modelled using the logarithmic form presented in 
column 2. The two specifications produced very similar results.
Individuals who had never used drugs, and even past users, had significantly higher 
life satisfaction than current drug users. Compared to current cannabis users, life satisfac-
tion was, on average, 0.33 scale points (3.0%) greater for past users, and 0.54 scale points 
(or 4.9%) greater for never users. Both specifications produced similar relative results. In 
terms of other drugs, compared to current users, life satisfaction was, on average across the 
two specifications, 0.35 scale points (3.2%) greater for past users, and 0.38 scale points (or 
3.5%) greater for never users.
The estimated coefficients related to alcohol consumption suggested that, compared to 
“never” as a reference category, drinking a couple of days a week was positively associated 
with life satisfaction (a 0.27 scale point or 25% increase). Drinking more than 5 days a 
week was negatively but not significantly associated with wellbeing.6
The findings for control variables showed that being unemployed, single/divorced and 
in poor health, was associated with lower life satisfaction than being employed, married 
and in good health respectively. Moreover, males had significantly lower life satisfaction 
than females.
Importantly for the current analyses, although the literature suggests that the relation-
ship between wellbeing and income may be better described by a semi-log model, our 
results, in terms of goodness of fit measures such as the log likelihood and Akaike’s Infor-
mation Criteria, suggested that the linear specification performs better, at least in the cur-
rent context.
(4)“unbiased” Compensation Value specification (2) = e
[
훽never drug
훿∗
+ln (M0)
]
−M0
6 Alternative specifications have been estimated. All results are available from the authors upon request. 
First, we included an interaction term between other drugs and cannabis. This variable can take 4 different 
values depending on whether the respondent has never taken any of these drugs, has taken both types of 
drug in the past, has taken one drug in the past and is taking one in the present, or is a current user of both 
drugs. Introducing the interaction terms, all coefficients related to the drug variables turned out not signifi-
cant (both for cannabis and other drugs and for the interaction terms). This may be linked to the relatively 
low number of individuals taking drugs other than cannabis in our sample.
 Second, we included an interaction term between alcohol consumption and drug use. Given that alcohol 
use is measured only in the present, we have introduced an interaction term of current drug use (of either 
cannabis or any other drug) and frequency of alcohol consumption. The coefficients and significance level 
of the original alcohol variables did not change, but the interaction terms between alcohol and drug use 
were not significant. Again, it should be noted that the data does not allow us to know whether alcohol and 
drugs have been taken together on the same occasions.
 Third we also attempted to separate out other types of drugs, but found little significant impact on wellbe-
ing—probably due to the low numbers of consumers and the lack of data about frequency. In addition we 
tried to categorise by type of drug (opiate, stimulant, downers, cocaine, amphetamine or Class A) but no 
significant impacts were found.
 A. Maccagnan et al.
1 3
Table 2  Estimation results. Source: Elaborations on CSEW 2013/14
(1)
Linear model
(2)
Semi-log model
Cannabis use
 Current user (ref.cat)
 Never user 0.541*** 0.530***
(0.160) (0.160)
 Past user 0.329** 0.331**
(0.154) (0.155)
Other drugs
 Current user (ref.cat)
 Never user 0.368** 0.388**
(0.182) (0.182)
 Past user 0.343* 0.353*
(0.180) (0.180)
Alcohol consumption
 Never (ref. cat.)
 Less than a day a week 0.126 0.118
(0.103) (0.103)
 1–2 days a week 0.270*** 0.267**
(0.103) (0.104)
 3–4 days a week 0.125 0.131
(0.116) (0.116)
 5+ days a week − 0.115 − 0.106
(0.136) (0.137)
Male − 0.225*** − 0.220***
(0.058) (0.058)
Age group
 16–24 (ref. cat.)
 25–44 − 0.186* − 0.184*
(0.109) (0.110)
 45–64 − 0.159 − 0.161
(0.116) (0.117)
Marital status
 Single (ref. cat.)
 Married/cohabiting 0.300*** 0.290***
(0.071) (0.071)
 Separated/divorced − 0.228** − 0.228**
(0.101) (0.101)
 Widowed − 0.505* − 0.497*
(0.275) (0.276)
Health status − 0.601*** − 0.607***
(0.041) (0.041)
Educational level
 None/Other qualification (ref. cat.)
 Degree − 0.189*** − 0.166**
(0.07) (0.069)
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6  Discussion
The regression results confirmed the harmful effect of using drugs on wellbeing. We found 
a difference in terms of types of drugs, with cannabis having a more detrimental effect than 
other types of drugs. This may be the result of the hypothesized lower frequency of use of 
drugs different from cannabis—which cannot be further investigated due to lack of data, or 
it may be indicative of a persistence in the wellbeing impacts of cannabinoids.
The result on alcohol consumption suggested that social drinkers have a higher life sat-
isfaction than abstainers. This confirms previous literature findings interpreting “recrea-
tional” drinking as a strategy to deal with stress or promote positive social relationships 
(Lanier, Nicholson, and Duncan 2001). Nevertheless, it is not possible to know whether it 
is drinking itself that increases wellbeing, or it is rather the time spent outside with friends 
that gives higher life satisfaction to those who drink in moderation.
Looking at the regression coefficients presented in Table 2, for a better understanding of 
the effect of drugs and drinking on our wellbeing, we can compare the magnitude of their 
effect to the effect of different variables. The positive effect of never having taken canna-
bis was similar but with opposite sign to the effect of being widowed. Hence, a widow/er 
Table 2  (continued)
(1)
Linear model
(2)
Semi-log model
 A-level 0.003 0.001
(0.082) (0.082)
Employment condition
 Employed (ref. cat.)
 Unemployed − 0.788*** − 0.754***
(0.168) (0.170)
 Student 0.273 0.317*
(0.186) (0.188)
 Other inactive − 0.214** − 0.193**
(0.097) (0.098)
Number of children 0.076** 0.065*
(0.033) (0.033)
Equivalised disposable income 0.017***
(0.003)
Log of Equivalised disposable income 0.217***
(0.044)
_cons 7.435*** 7.161***
(0.233) (0.247)
N 4405 4405
LL − 8966.667 − 8971.240
R squared 0.138 0.136
AIC 17,979.333 17,988.48
The income variable has been divided by 1000 for the ease of interpretation; health status is an ordinal vari-
able
***p <0.01; **p <0.05, *p <0.10
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that has never used cannabis is on average as happy as a single individual (controlling for 
age) who currently uses cannabis. A similar comparison can be made between being single 
versus married and using other kinds of drugs or not. Being in education vs. employed had 
a very close coefficient to drinking a couple of days a week vs. abstinence, although the 
former was hardly significant.
6.1  Policy Implications
In order to derive the policy implications of our findings, Table 3 presents the estimated 
wellbeing cost of being a current vs. past drug user and of being a current vs. never user. 
These figures have been computed following the procedure presented in Sect. 4.2, and in 
particular Eqs. (2) and (3), together with the regression results presented in Table 2. Equa-
tions (2) and (3) have been duly modified for computing the compensation value for being 
a current vs. past user, and the compensation value for not drinking alcohol vs. being a 
moderate drinker. As shown in Table 3, depending on the model specification (i.e. linear 
or semi-log specification), never having used cannabis was associated with wellbeing ben-
efits equivalent to an extra £32,788–£187,089 per annum compared to current users. Simi-
larly, the compensation a past user would need to maintain their wellbeing if they were 
to become a current user was estimated to be in the £19,939–£64,083 per annum range, 
depending on specification. As for other drugs, never having taken the drug was found to 
be “worth” £22,303–£88,686 per annum compared to current users and being a past user 
was associated with £20,788–£72,822 per annum, worth of wellbeing gains compared to 
current users.
These estimates may be useful in conducting cost-benefit analysis of actions to reha-
bilitate drug users or in actions to prevent drug use. For the case of rehabilitation, the cost 
of being a current user compared to being a past user should be used. When considering 
actions to prevent drug use (e.g. education campaigns) then the cost of being a current user 
compared to never using the drug in question should be used. It is important to note the 
persistent impact of drug taking on wellbeing.
These figures suggest that a policy intervention aimed at overcoming drug addiction 
(giving up current use and becoming a past user) may lead to a yearly £20,000 gain follow-
ing the linear specification for both use of cannabis and other drugs, and over £60,000 for 
cannabis and over £70,000 in the case of other drugs, following the semi-log specification.
As for drinking, we found that drinking a couple of days a week rather than never 
was equivalent to an extra income of £16,364 in the linear specification and £43,164 in 
Table 3  The compensation value 
of taking drugs and drinking by 
model specification
(1)
Linear model
(2)
Semi-log model
Cannabis: current user versu
 Never user £32,788 £187,089
 Past user £19,939 £64,083
Other drugs: current user versus
 Never user £22,303 £88,686
 Past user £20,788 £72,822
Drinking: never versus
 1–2 days a week £16,364 £43,164
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the semi-log specification. Intriguingly, according to the ONS (2017) average household 
expenditures on alcoholic drinks in the UK is £405 per year. Clearly the cost for alcohol 
consumption is far less than the potential income equivalent benefit from moderate drink-
ing in terms of life satisfaction.
As discussed earlier, an endogeneity problem for income exists. As no suitable instru-
mental variable was available in the CSEW, we have retrieved the unbiased estimated coef-
ficient for income 훿∗ from the papers by Powdthavee (2010) and Fujiwara et  al. (2014) 
(FKD hereafter).7 As both Powdthavee and FKD studies model the relationship between 
life satisfaction and income following a semi-logarithmic form, in the following we are 
going to focus on specification 2 only.
Table 4 presents the estimated unbiased cost of taking drugs, or the unbiased value of 
being a moderate drinker, computed following Eq. (4) and using Powdthavee (2010) and 
FKD unbiased income coefficient.
In particular, Table 4 presents three sets of results. Column 1 reports for a comparison 
the compensation values already presented in Table 3 following Specification 2. Column 2 
presents the compensation values of taking drugs and drinking computed using the results 
of the unbiased income coefficient derived from the Powdthavee’s paper; Column 3 pre-
sents the ones computed following the FKD paper. As it is also discussed in the Appendix, 
the figures in column 2 may be considered an upper bound of the “unbiased” cost of drugs 
and drinking, while the figures in column 3 may be considered a “lower bound”. These 
figures clearly suggest that when the endogeneity issue is taken into account, the wellbeing 
cost of taking drugs is sharply reduced. Following the Powdthavee (2010) income esti-
mate, the cost of taking drugs ended up being between 55 and 65% lower than our estimate, 
while following the FKD paper, this was reduced to less than 10% of our original esti-
mates. Of note, the values computed following FKD estimates were not far from the benefit 
of being off drugs estimated by DTORS (Donmall et al. 2009): approximately £6500 per 
person a year.
Turning to drinking behaviours, according to our estimates in the semi-log specifica-
tion drinking a couple of days a week rather than never was equivalent to an extra income 
Table 4  The compensation value of taking drugs and drinking by income coefficient estimate (semi-log 
specifications only)
(1)
CSEW OLS—specifica-
tion (2)
(2)
CSEW using Powdthavee IV 
(upper bound)
(3)
CSEW using 
FKD IV (lower 
bound)
Cannabis: current user versus
 Never user £187,089 £65,724 £5631
 Past user £64,083 £28,950 £3333
Other drugs: current user versus
 Never user £88,686 £37,404 £3967
 Past user £72,822 £32,047 £3576
Drinking: never versus
 1–2 days a week £43,164 £20,989 £2643
7 These are presented and discussed in the “Appendix”.
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of £43,164 a year. Taking into account the income endogeneity problem and following the 
same procedure used for evaluating drugs, we found that the unbiased value of being a 
social drinker was £20,989 following Powdthavee’s (2010) estimates and £2643 following 
the FKD study (Table 4). These figures are still significantly higher than the overall average 
cost of alcohol consumption of £405 per household per year (ONS 2017).
6.2  The Potential Wellbeing Benefits of Giving Up Drugs at the National Level
Considering the drug consumption statistics presented in Table 1, it is possible to calcu-
late the total wellbeing benefits of giving up drugs at the national level. In England and 
Wales the population aged 16 to 59 years (the age group of our data sample) is made up 
of approximately 33.5 m people (ONS 2016b), as the CSEW is a representative sample, 
we estimated the number of users on the basis of this population. In order to give figures 
which are as conservative as possible, changes in drug use habits were evaluated following 
the results derived using the FKD estimates (last column of Table 4).
Table 5 presents the wellbeing benefits current drug users may enjoy from giving up 
drugs. The potential benefit of giving up drugs was £10.7bn per year for England and 
Wales. This represents 0.6% of UK GDP in 2013. This benefit only reflects the wellbeing 
element, it does not reflect the potential reductions in healthcare costs or other associated 
costs of drug use (e.g. crime)—it is hence a lower bound. A number of studies have calcu-
lated the direct and indirect health and crime cost linked to illegal drug use for society. This 
is approximately 0.19% of GDP for Belgium (Lievens et al. 2017), 0.14% of GDP for Spain 
(Rivera et al. 2017) and 0.4% in the case of France (Kopp and Ogrodnik 2017).
In order to get a better grasp of the importance of the issue of drug use to society in 
comparison to other social issues, we can compare the benefit of giving up drugs to the 
avoidance of other social problems. For instance, our findings are in the same ballpark 
as the social cost of smoking, which is £13.74 billion in the UK (Nash and Featherstone 
2010), but lower than the social cost of air pollution, which is £54 billion per year in the 
UK (WHO and OECD 2015). There are significant threats to public health budgets around 
drug prevention and support services and it is important that efforts be made to reduce the 
significant costs to individuals and to society.
7  Summary
This paper explores the relationship between drug use and wellbeing, distinguishing 
between cannabis and other types of drugs, and between current and past drug users. Our 
results suggest a significant harmful effect of taking drugs on wellbeing, with individuals 
Table 5  The benefits of giving 
up drugs at the national level Estimated number Wellbeing benefit from 
giving up
Current cannabis users 1.862 m £6.208bn
Current users of other drugs 1.256 m £4.491bn
Total wellbeing benefits £10.700bn
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never having used cannabis having, for example, a life satisfaction score which is over 0.5 
higher compared to individuals that are currently using drugs.
Taking into account endogeneity in the relationship between income and wellbeing, we 
found that the compensating value for being a current cannabis user compared to not using 
the drug was between £5631 to £65,724. The similar cost for other drug use amounted to 
between £3967 to £37,404.
We also computed the effect of drinking on wellbeing, finding that drinking a couple 
of times a week rather than never is associated with extra 0.27 points life satisfaction. The 
welfare gain associated to being a social drinker is between £2643 and £20,989 a year.
As is true of any study of this type, our analysis suffers from a number of limitations. 
The data did not include information on intensity and frequency of drug use, so it was not 
possible to distinguish between occasional drug use and regular use. Moreover, we did not 
know how long before the interview the drug had been taken (e.g. could have been almost 
12 months ago), whether different types of drugs were taken together, or whether alcohol 
and drugs were mixed. Also, our focus was on the association between current use and 
wellbeing and we were unable to consider the effects of past users experiencing withdrawal 
symptoms which can also negatively affect wellbeing (Looby and Earleywine 2007).
Another issue which has already been highlighted in the existing literature is that the 
use of drugs (as well as of alcohol) is likely to be linked to wellbeing in a bidirectional 
relationship. Given the cross-sectional nature of the dataset used, we were not able to fully 
address this issue. Therefore, we must be aware that the estimated coefficients reflect asso-
ciations rather than causal relationships. To mitigate this problem, we have controlled for a 
number of personal characteristics, such as health status, employment condition and mari-
tal status, which could at least in part explain the endogeneity issue. Further research is 
needed into these relationships, including both qualitative work and improved data collec-
tion to facilitate the quantitative analysis of these relationships using, for example, struc-
tural equation models.
We were also unable to explore in greater depth the impact of other types of drugs 
because of a lack of data. It is likely that different drugs will have varying impacts on 
wellbeing.
We also computed the overall potential wellbeing benefit that could be enjoyed by 
giving up drugs at the national level. This was estimated to be £10.7 billion per year in 
England and Wales. This is equivalent to the social cost of smoking—and suggests there 
is much to be gained from strategies to reduce drug use. Moreover, this figure does not 
accounts for the wider benefits of reducing drug use to society—in terms of crime and 
the wider health implications. However, the wellbeing benefits of reducing drug use are 
shown to be high, even under the most conservative assumptions. Drug prevention and 
support services need to be appropriately funded to ensure that some of these benefits can 
be captured.
8  Conclusions
This paper has presented a first attempt to value the impact of alcohol and drug use using 
the wellbeing valuation approach. The findings suggest that, in terms of wellbeing, there is 
a small benefit to moderate alcohol consumption. In terms of drugs, current and past drug 
use is associated with important reductions in wellbeing—which would suggest that efforts 
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need to be placed into services to discourage illicit drug use and that future drug policy 
(including legalisation) should be carefully designed with societal wellbeing in mind.
The values for current losses may seem unrealistically high, compared to the average 
level of income of the population. Moreover, if we asked people how much they would be 
willing to pay to avoid the negative consequences of drug misuse, the numbers we would 
likely get would be much lower. This is because eliciting information on willingness to pay 
for non-market goods using survey methods is constrained by the budgets of the individu-
als. On the other hand, the life satisfaction approach does not depend on income8 and using 
such estimates in cost-benefit analysis may lead to better estimation of the true gains in 
welfare terms from the promotion of drug avoidance.
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Appendix
In this study we retrieved the “causal effect” of income on life satisfaction from two papers 
using for this end an instrumental variable approach. In particular, Fujiwara et al. (2014) 
used lottery wins as an instrument, while Powdthavee (2010) used the information about 
the use of a payslip during the interview. In using the estimated coefficients from these 
papers, a number of caveats should be taken into account. First, both analyses used British 
Panel Household Survey (BHPS) data, which are actually representative of the UK as a 
whole, while the CSEW is representative of England and Wales only. Given that the popu-
lation of England and Wales makes up almost 90% of the overall British population (ONS 
2016b) we do not believe this will unduly influence our results. Second, BHPS measures 
life satisfaction on a 1–7 scale, while the CSEW uses a 0–10 scale. Following Easterlin and 
Onnicha (2009), we assume that the two measurement scales can be linearly rescaled, and 
that a life satisfaction equal to 0 in the 0–10 scale corresponds to a life satisfaction of 1 in 
the 1–7 scale, while scoring the maximum of 10 in the 0–10 scale is equivalent to scoring 
8 see Powdthavee and Van den Berg (2011) on this issue and on the differences between contingent valua-
tion methods and the life satisfaction approach in the valuation of health and social outcomes, as well as on 
the limits of the two methods.
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7 in the BHPS scale. This can equivalently be done by transforming the estimated income 
coefficient computed on BHPS data multiplying it by 10/6. Third, while both papers also 
used a semi-log functional form for income (as we do in specification 2), in the current 
paper income is defined in a slightly different way. Fujiwara et al. (2014) used equivalised 
household income but did not specify the equivalence scale used. Powdthavee (2010) used 
the square root of the number of household members to derive the equivalent household 
income. Nevertheless, he also stated that when changing the definition of income, its coef-
ficient remained “virtually the same” (p. 85). These issues notwithstanding, we believe that 
using the estimated coefficients from these papers is thus not unreasonable, and consider 
them as estimates of the causal effect of income on wellbeing.
Table  6 presents the income coefficient estimates from the studies by Powdthavee 
(2010) and Fujiwara et  al. (2014). Both OLS and IV estimates are reported. Comparing 
OLS and IV regression coefficients, one can see that in both cases the IV estimate is higher 
than the OLS. This is in line with the literature, which suggests that higher income usually 
comes with longer working hours, as well as with higher comparison incomes, both of 
which increase stress reducing wellbeing.
As both studies by by Powdthavee (2010) and Fujiwara et  al. (2014) used life satis-
faction data measured on a 1–7 scale, Table 6 also presents the coefficient linearly trans-
formed onto a 0–10 scale (as explained above), and, for a comparison, our estimated coef-
ficient based on the CSEW data.
Although the OLS estimates reported in Table 6 are quite close to each other (and to 
our coefficient as well), the two IV estimates differ substantially. This is likely to be the 
result of the different control variables used in these regressions, with Powdthavee (2010) 
considering a much larger control vector than FKD (2014).9 We used the values of 0.343 
and 1.930 as possible bounds of the unbiased income coefficient 훿∗ , and computed what we 
consider the “lower” and “upper bound” of the unbiased cost of taking drugs, or the unbi-
ased value of being a moderate drinker, following Eq. (4). These are presented in Table 4 
in the text.
Table 6  Comparison of the 
estimated regression coefficients 
of income
a This is the result of the IV-FE model
b The OLS model is computed on Understanding Society data
Original 1–7 scale Transformed 0–10 
scale
OLS IV OLS IV
Powdthavee (2010) 0.105 0.206a 0.175 0.343
Fujiwara et al. (2014) 0.124–0.132b 1.158 0.207–0.220 1.930
CSEW (our estimate) 0.217
9 On the effect of additional controls see e.g. the models presented in tables IV to VI by Angrist and Krue-
ger (1991).
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